Jefferies Financial Group Comments on Nu Skin Enterprises, Inc.’s Q2 2022 Earnings (NYSE:NUS)

Nu Skin Enterprises, Inc. (NYSE:NUSGet Rating) – Analysts at Jefferies Financial Group reduced their Q2 2022 earnings per share (EPS) estimates for shares of Nu Skin Enterprises in a report released on Wednesday, May 4th. Jefferies Financial Group analyst S. Wissink now anticipates that the company will post earnings per share of $0.78 for the quarter, down from their previous forecast of $1.31. Jefferies Financial Group also issued estimates for Nu Skin Enterprises’ Q4 2022 earnings at $1.19 EPS, FY2022 earnings at $3.73 EPS, Q2 2023 earnings at $0.88 EPS, FY2024 earnings at $4.54 EPS and FY2025 earnings at $5.16 EPS.

A number of other equities analysts also recently issued reports on the company. StockNews.com raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Thursday. TheStreet downgraded Nu Skin Enterprises from a “b” rating to a “c+” rating in a report on Friday, February 18th. Zacks Investment Research raised Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $57.00 price target for the company in a report on Tuesday, March 29th. Finally, DA Davidson boosted their price objective on Nu Skin Enterprises from $47.00 to $50.00 and gave the company a “neutral” rating in a research note on Thursday, February 17th. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Nu Skin Enterprises has a consensus rating of “Buy” and a consensus target price of $60.60.

Shares of NUS opened at $44.48 on Monday. The stock has a 50 day moving average price of $46.92 and a 200 day moving average price of $47.74. The company has a quick ratio of 0.89, a current ratio of 1.72 and a debt-to-equity ratio of 0.28. The company has a market capitalization of $2.22 billion, a price-to-earnings ratio of 16.47 and a beta of 1.24. Nu Skin Enterprises has a 52-week low of $39.40 and a 52-week high of $62.70.

Nu Skin Enterprises (NYSE:NUSGet Rating) last announced its quarterly earnings data on Wednesday, May 4th. The company reported $0.76 EPS for the quarter, topping analysts’ consensus estimates of $0.72 by $0.04. Nu Skin Enterprises had a return on equity of 22.05% and a net margin of 5.28%. The business had revenue of $604.90 million during the quarter, compared to the consensus estimate of $579.70 million. During the same period in the previous year, the company posted $0.91 earnings per share. The business’s revenue for the quarter was down 10.7% on a year-over-year basis.

A number of large investors have recently added to or reduced their stakes in NUS. TCI Wealth Advisors Inc. raised its position in Nu Skin Enterprises by 66.6% in the fourth quarter. TCI Wealth Advisors Inc. now owns 758 shares of the company’s stock worth $38,000 after acquiring an additional 303 shares in the last quarter. Covestor Ltd purchased a new position in Nu Skin Enterprises in the fourth quarter worth $48,000. Quadrant Capital Group LLC raised its position in Nu Skin Enterprises by 47.1% in the fourth quarter. Quadrant Capital Group LLC now owns 1,068 shares of the company’s stock worth $54,000 after acquiring an additional 342 shares in the last quarter. JJJ Advisors Inc. raised its position in Nu Skin Enterprises by 216.9% in the fourth quarter. JJJ Advisors Inc. now owns 1,870 shares of the company’s stock worth $95,000 after acquiring an additional 1,280 shares in the last quarter. Finally, Gladius Capital Management LP purchased a new position in Nu Skin Enterprises in the fourth quarter worth $98,000. Hedge funds and other institutional investors own 93.79% of the company’s stock.

In other news, Director Andrew D. Lipman sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 22nd. The stock was sold at an average price of $53.27, for a total transaction of $53,270.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Ryan S. Napierski sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, February 25th. The stock was sold at an average price of $47.40, for a total value of $1,185,000.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 28,000 shares of company stock valued at $1,333,390. 2.80% of the stock is owned by company insiders.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 8th. Shareholders of record on Friday, May 27th will be paid a $0.385 dividend. This represents a $1.54 dividend on an annualized basis and a yield of 3.46%. The ex-dividend date of this dividend is Thursday, May 26th. Nu Skin Enterprises’s dividend payout ratio is currently 57.04%.

About Nu Skin Enterprises (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

See Also

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.